CINGULATE INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6611 USD | -4.59% |
|
-8.54% | -91.36% |
| 05-21 | FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHD | CI |
| 05-08 | Cingulate Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CINGULATE INC. | Other Biotechnology & Medical Research | -4.59% | -8.54% | -91.36% | -96.59% | - | 4.57M |  | | |
- Stock Market
- Equities
- CING Stock
- Charts Cingulate Inc.
- Relative Strength Chart